학술논문
668P Efficacy and safety of larotrectinib in a pooled analysis of patients (Pts) with tropomyosin receptor kinase (TRK) fusion cancer
Document Type
Abstract
Author
Source
In Annals of Oncology October 2023 34 Supplement 2:S470-S470
Subject
Language
ISSN
0923-7534